Your browser doesn't support javascript.
loading
Mapping the naloxone binding sites on the mu-opioid receptor using cell-based photocrosslinkers.
Ke, Yi-Yu; Huang, Yi-Han; Chien, Wei-Chuan; Loh, Horace H; Chuang, Jian-Ying; Yeh, Shiu-Hwa.
Afiliação
  • Ke YY; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan.
  • Huang YH; Graduate Institute of Neural Regenerative Medicine, Taipei Medical University, Taiwan.
  • Chien WC; Graduate Institute of Neural Regenerative Medicine, Taipei Medical University, Taiwan.
  • Loh HH; Department of Pharmacology, University of Minnesota, USA.
  • Chuang JY; Graduate Institute of Neural Regenerative Medicine, Taipei Medical University, Taiwan; Center for Neurotrauma and Neuroregeneration, Taipei Medical University, Taiwan. Electronic address: chuangcy@tmu.edu.tw.
  • Yeh SH; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan. Electronic address: bau9763@bp.nhri.org.tw.
Biochim Biophys Acta Proteins Proteom ; 1865(3): 336-343, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28012872
ABSTRACT
Naloxone is an alkaloid antagonist that acts as an antidote to opioids through the mu-opioid receptor (MOR), a G protein-coupled receptor. However, its binding site on the MOR remains unknown. To investigate the binding interfaces necessary for naloxone and MOR, available structural information was combined with a cell-based photocrosslinking approach. Computer prediction revealed that four binding sites on MOR were required for naloxone binding. In addition, in the photocrosslinking approach, an amber stop codon was used to replace the sense codon of the MOR at 266 selected individual positions, in order to introduce the photoreactive amino acid p-benzoyl-l-phenylalanine (BzF) into MOR to evaluate the results of the computer analysis. The BzF-incorporated MOR mutant genes were expressed in CHO cells, in which MOR retained the ability to interact with its ligands, such as morphine, and exhibited MOR-dependent activation of ERK signaling following morphine stimulation. Notably, after treatment with tritium-labeled naloxone and exposure to UV light, we observed naloxone crosslinking with BzF replacement at hydrophobic residues and some polar/uncharged residues in the computer-predicted sites 1 and 3, indicating that these two sites in the MOR interact with naloxone. In conclusion, these results indicate that MOR has two naloxone binding sites and that the hydrophobic and polar/uncharged residues within these sites are important for naloxone binding.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Opioides mu / Reagentes de Ligações Cruzadas / Naloxona Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biochim Biophys Acta Proteins Proteom Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Opioides mu / Reagentes de Ligações Cruzadas / Naloxona Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biochim Biophys Acta Proteins Proteom Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Taiwan